Zhao Y, Zhang J, Xue B, Zhang F, Xu Q, Ma H, Sha T, Peng L, Li F, Ding J. Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary tuberculosis.
J Int Med Res 2021;
49:3000605211036832. [PMID:
34463584 PMCID:
PMC8414942 DOI:
10.1177/03000605211036832]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Objective
To analyze serum levels of inhibitory costimulatory molecules and their
correlations with innate immune cytokine levels in patients with pulmonary
tuberculosis (PTB).
Methods
Data for 280 PTB patients and 280 healthy individuals were collected. Serum
levels of immune molecules were measured using ELISA. Univariate,
multivariate, subgroup, matrix correlation, and receiver operating
characteristic curve analyses were performed.
Results
Host, environment, lifestyle, clinical features, and medical history all
influenced PTB. Serum levels of soluble programmed death ligand 1 (sPD-L1),
soluble T-cell immunoglobulin- and mucin-domain–containing molecule 3
(sTim-3), soluble galectin-9 (sGal-9), interleukin (IL)-4, and IL-33 were
significantly higher in patients with PTB, while levels of IL-12, IL-23,
IL-18, and interferon (IFN)-γ were significantly lower. Serum levels of
sTim-3 were higher in alcohol users. Levels of sTim-3 were negatively
correlated with those of IL-12. Levels of IL-12, IL-23, and IL-18 were
positively correlated with those of IFN-γ, while levels of IL-12 were
negatively correlated with those of IL-4. The areas under the curve of
sPD-L1, sTim-3, sGal-9, IL-12, IL-23, IL-18, IFN-γ, IL-4, and IL-33 for
identifying PTB were all >0.77.
Conclusions
Inhibitory costimulatory molecules may be targets for controlling PTB. Immune
molecules may be helpful for diagnosis of PTB.
Collapse